Valproic acid (VPA) serves primarily as an anticonvulsant and a cornerstone mood stabilizer for bipolar disorder. However, emerging preclinical evidence suggests its utility extends further. A comprehensive systematic review and meta-analysis recently explored valproic acid antidepressant effects in rodent models of stress-induced depression. These findings offer significant insights into the potential neuroprotective and mood-regulating properties of this established medication.

The research team examined data from several validated behavioral assays, including the Forced Swimming Test (FST), Open Field Test (OFT), and Sucrose Preference Test (SPT). Their systematic evaluation included sixteen separate experiments for the FST alone. Consequently, the researchers identified a consistent pattern of improved behavioral outcomes following VPA administration.

Analyzing Valproic Acid Antidepressant Effects in Behavioral Models

Meta-analysis results showed that VPA significantly reduced the percentage of immobility in the FST. Specifically, the standardized mean difference (SMD) was -0.93, indicating a strong effect in lowering stress-related despair compared to untreated groups. Furthermore, results from nine experiments in the Sucrose Preference Test demonstrated that VPA increased the animals' desire for rewards. This suggests that the drug effectively counters anhedonia, which is a core symptom of clinical depression.

Regarding dosage, the study highlighted that administering VPA at 300 mg/kg/day via injection for four consecutive weeks significantly decreased depressive symptoms. Additionally, horizontal and vertical movement scores in the Open Field Test increased, implying higher activity levels and reduced anxiety. However, the analysis of the Novel Object Recognition (NOR) test showed no significant effect on the animals' ability to identify new objects. Therefore, while VPA impacts mood and motivation, its effect on specific memory recognition tasks may be limited in these stress models.

Despite these promising results, the researchers noted significant heterogeneity and a risk of publication bias. They advised caution when interpreting these findings for immediate clinical translation. Future studies should focus on refining the therapeutic windows and understanding the precise molecular mechanisms, such as histone deacetylase (HDAC) inhibition, behind these antidepressant-like actions.

Frequently Asked Questions

What was the effective dosage of valproic acid in these models?

The meta-analysis found that a dosage of 300 mg/kg/day, administered via injection for four weeks, significantly reduced depressive-like behaviors in the rodent models studied.

How does valproic acid impact anhedonia in these studies?

Results from the Sucrose Preference Test indicated that valproic acid significantly increased the animals' preference for sucrose water, suggesting it may help reverse stress-induced anhedonia.

Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified health provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.

References

1. Goudarzi M et al. Valproic acid effects on stress-induced depression-like behavior in rodent models: a systematic review and meta-analysis. Stress. 2026 Dec 31. doi: 10.1080/10253890.2026.2641561. PMID: 41826267.

2. Goudarzi M et al. Valproic acid administration exerts protective effects against stress-related anhedonia in rats. J Chem Neuroanat. 2020 Apr;105:101768. doi: 10.1016/j.jchemneu.2020.101768.

3. Lima MG et al. Valproate as an antidepressant in major depressive disorder: a systematic review. Journal of Affective Disorders. 2017;218:230-236.